CBU
TEVA icon

CIBC Bank USA’s Teva Pharmaceuticals TEVA Stock Holding History

CIBC Bank USA’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-12,965
Closed -$120K – 283
2019
Q2 		$120K Buy
+12,965
New +$156K 0.02% 259
2018
Q4 		– Sell
-9,965
Closed -$215K – 264
2018
Q3 		$215K Sell
9,965
-1,121
-10% -$26K 0.03% 238
2018
Q2 		$270K Buy
+11,086
New +$226K 0.04% 206
2017
Q1 		– Sell
-6,490
Closed -$235K – 271
2016
Q4 		$235K Sell
6,490
-1,002
-13% -$40K 0.03% 227
2016
Q3 		$345K Buy
7,492
+522
+7% +$27.2K 0.05% 191
2016
Q2 		$350K Buy
6,970
+1,449
+26% +$77.1K 0.05% 173
2016
Q1 		$295K Buy
5,521
+342
+7% +$20.1K 0.05% 172
2015
Q4 		$340K Sell
5,179
-165
-3% -$10.2K 0.06% 182
2015
Q3 		$302K Buy
5,344
+1,387
+35% +$89.9K 0.06% 190
2015
Q2 		$235K Buy
3,957
+230
+6% +$14.2K 0.04% 237
2015
Q1 		$231K Sell
3,727
-529
-12% -$30.8K 0.04% 234
2014
Q4 		$245K Buy
+4,256
New +$237K 0.04% 253

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return

CIBC Bank USA's TEVA Position: Q3 2019 in Review

CIBC Bank USA sold out of Teva Pharmaceuticals (TEVA) in Q3 2019, closing a stake of 12,965 shares — an estimated $120K sold.

CIBC Bank USA first reported a position in TEVA in Q4 2014 and held it in 12 quarters. The position peaked at $350K in Q2 2016. 427 funds tracked by Wall St. Rank hold TEVA as of Q3 2019.

  • CIBC Bank USA reported no remaining Teva Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • CIBC Bank USA sold 12,965 Teva Pharmaceuticals shares in Q3 2019, an estimated $120K.
  • CIBC Bank USA first reported a position in Teva Pharmaceuticals in Q4 2014 and held it in 12 quarters.
  • CIBC Bank USA's Teva Pharmaceuticals position peaked at $350K in Q2 2016.
  • 427 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2019.

Based on CIBC Bank USA's 13F filing for Q3 2019, filed 22 Oct 2019.